Format

Send to

Choose Destination
Environ Toxicol Pharmacol. 2014 Nov;38(3):845-51. doi: 10.1016/j.etap.2014.10.008. Epub 2014 Oct 22.

Impaired development of female mouse offspring maternally exposed to simazine.

Author information

1
School of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea; Department of Life Science, Chung-Ang University, Seoul 156-756, Republic of Korea.
2
School of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea.
3
Department of Life Science, Chung-Ang University, Seoul 156-756, Republic of Korea. Electronic address: kangseok@cau.ac.kr.
4
School of Pharmacy, Chung-Ang University, Seoul 156-756, Republic of Korea. Electronic address: jeehyeon@cau.ac.kr.

Abstract

Simazine is a suspected endocrine disruptor and the second most commonly detected pesticide in surface and groundwater worldwide. We evaluated the toxicity of simazine in female mouse offspring with in utero and lactational exposure to the agent. Pregnant mice were exposed to environmentally relevant doses (from 5 to 500μg/kg) of simazine via oral administration, and their female offspring were then analyzed. The female offspring showed shortened anogenital distance and decreased whole body, ovarian, and uterine weights. Their ovaries showed increased apoptotic granulosa cells. In addition, expression of critical genes involved in regulation of cellular apoptosis and proliferation was significantly downregulated in the ovaries of simazine-exposed mice. Moreover, in vitro exposure of human granulosa cell-derived KGN cells to simazine (0.003-1nM) resulted in decreased viability and proliferation. Thus, the present study demonstrates that maternal exposure to low doses of simazine impairs normal development of female offspring via disturbance of cellular apoptosis and proliferation.

KEYWORDS:

Apoptosis; Maternal exposure; Ovary; Proliferation; Reproductive toxicology

PMID:
25461544
DOI:
10.1016/j.etap.2014.10.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center